| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 1.86e-11 | 4 | 43 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 1.86e-11 | 4 | 43 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 9.30e-11 | 5 | 43 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 6.49e-10 | 7 | 43 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 2.33e-09 | 9 | 43 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 3.88e-09 | 10 | 43 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 1.31e-08 | 13 | 43 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 5.31e-06 | 323 | 43 | 7 | GO:1901681 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 5.87e-06 | 55 | 43 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.92e-05 | 74 | 43 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | lipoprotein lipase activity | 1.62e-04 | 9 | 43 | 2 | GO:0004465 | |
| GeneOntologyMolecularFunction | phosphatidylserine 1-acylhydrolase activity | 2.95e-04 | 12 | 43 | 2 | GO:0052739 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 3.03e-04 | 431 | 43 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | phospholipase A1 activity | 7.57e-04 | 19 | 43 | 2 | GO:0008970 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 8.40e-04 | 20 | 43 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 1.42e-03 | 26 | 43 | 2 | GO:0004806 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.58e-03 | 35 | 43 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.58e-03 | 35 | 43 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 4.23e-03 | 45 | 43 | 2 | GO:0043495 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 8.17e-11 | 5 | 43 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 3.82e-08 | 17 | 43 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 3.82e-08 | 17 | 43 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 3.82e-08 | 17 | 43 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 4.90e-08 | 18 | 43 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.41e-07 | 23 | 43 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 2.77e-07 | 27 | 43 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.19e-07 | 73 | 43 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 4.49e-07 | 74 | 43 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 4.49e-07 | 74 | 43 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 1.00e-06 | 10 | 43 | 3 | GO:0042420 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 1.38e-06 | 11 | 43 | 3 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 1.38e-06 | 11 | 43 | 3 | GO:0019614 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.38e-06 | 13 | 43 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 2.74e-06 | 47 | 43 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 3.02e-06 | 14 | 43 | 3 | GO:0019336 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 4.12e-06 | 52 | 43 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 5.15e-06 | 121 | 43 | 5 | GO:0006576 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 9.39e-06 | 20 | 43 | 3 | GO:0042402 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 1.12e-05 | 142 | 43 | 5 | GO:0018958 | |
| GeneOntologyBiologicalProcess | amine catabolic process | 1.26e-05 | 22 | 43 | 3 | GO:0009310 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 1.37e-05 | 148 | 43 | 5 | GO:0009308 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 2.09e-05 | 412 | 43 | 7 | GO:0006066 | |
| GeneOntologyBiologicalProcess | triglyceride catabolic process | 3.29e-05 | 30 | 43 | 3 | GO:0019433 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle remodeling | 5.74e-05 | 36 | 43 | 3 | GO:0034369 | |
| GeneOntologyBiologicalProcess | protein-lipid complex remodeling | 5.74e-05 | 36 | 43 | 3 | GO:0034368 | |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 6.23e-05 | 103 | 43 | 4 | GO:0097006 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 6.97e-05 | 106 | 43 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | protein-containing complex remodeling | 7.32e-05 | 39 | 43 | 3 | GO:0034367 | |
| GeneOntologyBiologicalProcess | neutral lipid catabolic process | 8.51e-05 | 41 | 43 | 3 | GO:0046461 | |
| GeneOntologyBiologicalProcess | acylglycerol catabolic process | 8.51e-05 | 41 | 43 | 3 | GO:0046464 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol storage | 1.18e-04 | 8 | 43 | 2 | GO:0010886 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.22e-04 | 376 | 43 | 6 | GO:0008202 | |
| GeneOntologyBiologicalProcess | dopamine metabolic process | 1.84e-04 | 53 | 43 | 3 | GO:0042417 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle organization | 2.05e-04 | 55 | 43 | 3 | GO:0071827 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.10e-04 | 141 | 43 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 2.16e-04 | 142 | 43 | 4 | GO:0034032 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 2.16e-04 | 142 | 43 | 4 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 2.16e-04 | 142 | 43 | 4 | GO:0033875 | |
| GeneOntologyBiologicalProcess | protein-lipid complex organization | 2.53e-04 | 59 | 43 | 3 | GO:0071825 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 2.58e-04 | 432 | 43 | 6 | GO:0050911 | |
| GeneOntologyBiologicalProcess | plasma lipoprotein particle clearance | 3.07e-04 | 63 | 43 | 3 | GO:0034381 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 3.30e-04 | 641 | 43 | 7 | GO:1901615 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 3.40e-04 | 160 | 43 | 4 | GO:0051384 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 3.82e-04 | 465 | 43 | 6 | GO:0007608 | |
| GeneOntologyBiologicalProcess | glycerolipid catabolic process | 4.19e-04 | 70 | 43 | 3 | GO:0046503 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 4.78e-04 | 485 | 43 | 6 | GO:0050907 | |
| GeneOntologyBiologicalProcess | high-density lipoprotein particle remodeling | 5.66e-04 | 17 | 43 | 2 | GO:0034375 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 5.88e-04 | 185 | 43 | 4 | GO:0031960 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 6.72e-04 | 722 | 43 | 7 | GO:0051606 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage derived foam cell differentiation | 7.10e-04 | 19 | 43 | 2 | GO:0010744 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 7.17e-04 | 524 | 43 | 6 | GO:0009593 | |
| GeneOntologyBiologicalProcess | regulation of cholesterol storage | 7.88e-04 | 20 | 43 | 2 | GO:0010885 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 8.96e-04 | 547 | 43 | 6 | GO:0007606 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.16e-03 | 222 | 43 | 4 | GO:0071466 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 1.23e-03 | 582 | 43 | 6 | GO:0050906 | |
| GeneOntologyBiologicalProcess | cholesterol storage | 1.34e-03 | 26 | 43 | 2 | GO:0010878 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 1.52e-03 | 239 | 43 | 4 | GO:0031032 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid storage | 1.66e-03 | 29 | 43 | 2 | GO:0010884 | |
| GeneOntologyBiologicalProcess | cholesterol homeostasis | 2.20e-03 | 124 | 43 | 3 | GO:0042632 | |
| GeneOntologyBiologicalProcess | sterol homeostasis | 2.25e-03 | 125 | 43 | 3 | GO:0055092 | |
| GeneOntologyBiologicalProcess | regulation of macrophage derived foam cell differentiation | 2.28e-03 | 34 | 43 | 2 | GO:0010743 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 2.30e-03 | 126 | 43 | 3 | GO:1903035 | |
| GeneOntologyBiologicalProcess | triglyceride metabolic process | 2.35e-03 | 127 | 43 | 3 | GO:0006641 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 2.46e-03 | 129 | 43 | 3 | GO:1905954 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.92e-03 | 286 | 43 | 4 | GO:0042445 | |
| GeneOntologyCellularComponent | triglyceride-rich plasma lipoprotein particle | 1.59e-05 | 24 | 43 | 3 | GO:0034385 | |
| GeneOntologyCellularComponent | very-low-density lipoprotein particle | 1.59e-05 | 24 | 43 | 3 | GO:0034361 | |
| GeneOntologyCellularComponent | lipoprotein particle | 1.01e-04 | 44 | 43 | 3 | GO:1990777 | |
| GeneOntologyCellularComponent | plasma lipoprotein particle | 1.01e-04 | 44 | 43 | 3 | GO:0034358 | |
| GeneOntologyCellularComponent | protein-lipid complex | 1.23e-04 | 47 | 43 | 3 | GO:0032994 | |
| GeneOntologyCellularComponent | chylomicron | 3.18e-04 | 13 | 43 | 2 | GO:0042627 | |
| GeneOntologyCellularComponent | sarcomere | 1.68e-03 | 249 | 43 | 4 | GO:0030017 | |
| MousePheno | enlarged gallbladder | 3.40e-07 | 28 | 30 | 4 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 5.94e-07 | 32 | 30 | 4 | MP:0020134 | |
| MousePheno | abnormal gallbladder morphology | 7.73e-06 | 60 | 30 | 4 | MP:0005084 | |
| MousePheno | enlarged thymus | 3.07e-05 | 292 | 30 | 6 | MP:0000709 | |
| MousePheno | abnormal skeletal muscle morphology | 7.89e-05 | 508 | 30 | 7 | MP:0000759 | |
| MousePheno | abnormal biliary tract morphology | 1.08e-04 | 117 | 30 | 4 | MP:0005083 | |
| MousePheno | increased circulating phospholipid level | 1.98e-04 | 10 | 30 | 2 | MP:0003980 | |
| Domain | Sulfotransferase_dom | 1.23e-06 | 36 | 42 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.23e-06 | 36 | 42 | 4 | PF00685 | |
| Domain | Lipo_Lipase | 4.94e-06 | 2 | 42 | 2 | IPR002330 | |
| Domain | LH2 | 8.43e-06 | 18 | 42 | 3 | SM00308 | |
| Domain | PLAT | 1.37e-05 | 21 | 42 | 3 | PF01477 | |
| Domain | PLAT | 1.37e-05 | 21 | 42 | 3 | PS50095 | |
| Domain | PLAT/LH2_dom | 1.37e-05 | 21 | 42 | 3 | IPR001024 | |
| Domain | - | 1.37e-05 | 21 | 42 | 3 | 2.60.60.20 | |
| Domain | Lipase_LIPH | 2.20e-04 | 10 | 42 | 2 | IPR016272 | |
| Domain | Lipase | 2.20e-04 | 10 | 42 | 2 | PF00151 | |
| Domain | Lipase_N | 2.20e-04 | 10 | 42 | 2 | IPR033906 | |
| Domain | Lipase/vitellogenin | 2.20e-04 | 10 | 42 | 2 | IPR013818 | |
| Domain | TAG_lipase | 2.20e-04 | 10 | 42 | 2 | IPR000734 | |
| Domain | LIPASE_SER | 1.55e-03 | 26 | 42 | 2 | PS00120 | |
| Domain | Olfact_rcpt | 1.80e-03 | 393 | 42 | 5 | IPR000725 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 1.24e-10 | 5 | 33 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 1.75e-08 | 13 | 33 | 4 | M18256 | |
| Pathway | WP_RETINOL_METABOLISM | 5.21e-08 | 44 | 33 | 5 | MM15851 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.77e-07 | 22 | 33 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 2.14e-07 | 23 | 33 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 2.56e-07 | 24 | 33 | 4 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.93e-06 | 39 | 33 | 4 | MM15695 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 7.77e-06 | 17 | 33 | 3 | M39483 | |
| Pathway | WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES | 7.77e-06 | 17 | 33 | 3 | M39747 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 1.26e-05 | 62 | 33 | 4 | MM14686 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 2.60e-05 | 25 | 33 | 3 | MM15562 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 2.69e-05 | 75 | 33 | 4 | M27032 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.10e-05 | 29 | 33 | 3 | M45015 | |
| Pathway | REACTOME_VLDL_CLEARANCE | 5.29e-05 | 5 | 33 | 2 | MM15567 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 6.66e-05 | 34 | 33 | 3 | M27842 | |
| Pathway | REACTOME_VLDL_CLEARANCE | 7.92e-05 | 6 | 33 | 2 | M27848 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 7.92e-05 | 6 | 33 | 2 | M39437 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 8.37e-05 | 636 | 33 | 8 | M41834 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.08e-04 | 107 | 33 | 4 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.16e-04 | 109 | 33 | 4 | M18788 | |
| Pathway | REACTOME_DRUG_ADME | 1.63e-04 | 119 | 33 | 4 | MM15692 | |
| Pathway | REACTOME_CHYLOMICRON_REMODELING | 1.89e-04 | 9 | 33 | 2 | MM15563 | |
| Pathway | WP_LIPID_PARTICLES_COMPOSITION | 2.36e-04 | 10 | 33 | 2 | M39697 | |
| Pathway | REACTOME_CHYLOMICRON_REMODELING | 2.36e-04 | 10 | 33 | 2 | M27843 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 3.63e-04 | 417 | 33 | 6 | M4072 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 4.08e-04 | 13 | 33 | 2 | M42551 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 4.27e-04 | 153 | 33 | 4 | MM15844 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 6.24e-04 | 72 | 33 | 3 | M46457 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2 | 6.25e-04 | 16 | 33 | 2 | M42564 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 9.64e-04 | 190 | 33 | 4 | MM15687 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.63e-03 | 219 | 33 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.66e-03 | 220 | 33 | 4 | M10320 | |
| Pathway | REACTOME_DRUG_ADME | 2.07e-03 | 109 | 33 | 3 | M45012 | |
| Pathway | WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION | 2.37e-03 | 31 | 33 | 2 | M39514 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 2.84e-03 | 34 | 33 | 2 | MM15566 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE | 3.36e-03 | 37 | 33 | 2 | M27847 | |
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 8943792 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 2.02e-12 | 4 | 43 | 4 | 12390022 | |
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 24318996 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 8424956 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 25370010 | ||
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 33414449 | ||
| Pubmed | 1.01e-11 | 5 | 43 | 4 | 11389699 | ||
| Pubmed | 1.01e-11 | 5 | 43 | 4 | 29908303 | ||
| Pubmed | 1.01e-11 | 5 | 43 | 4 | 24802129 | ||
| Pubmed | 1.01e-11 | 5 | 43 | 4 | 25053625 | ||
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 9370299 | ||
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 12438748 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 1.41e-10 | 8 | 43 | 4 | 10594240 | |
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 9166597 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 2.54e-10 | 9 | 43 | 4 | 9060415 | |
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 8887328 | ||
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 9177785 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 2.54e-10 | 9 | 43 | 4 | 23207770 | |
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 8468045 | ||
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 19548878 | ||
| Pubmed | 4.23e-10 | 10 | 43 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 6.64e-10 | 11 | 43 | 4 | 7613026 | |
| Pubmed | 6.64e-10 | 11 | 43 | 4 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 6.64e-10 | 11 | 43 | 4 | 9034160 | |
| Pubmed | 6.64e-10 | 11 | 43 | 4 | 10720750 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 6.64e-10 | 11 | 43 | 4 | 8954725 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 9.95e-10 | 12 | 43 | 4 | 7706460 | |
| Pubmed | 1.44e-09 | 13 | 43 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 1.44e-09 | 13 | 43 | 4 | 17425406 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 8912648 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 1.76e-09 | 3 | 43 | 3 | 8363592 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 9855620 | ||
| Pubmed | 2.74e-09 | 15 | 43 | 4 | 1741163 | ||
| Pubmed | 6.12e-09 | 18 | 43 | 4 | 20056724 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 32152050 | ||
| Pubmed | 1.19e-08 | 21 | 43 | 4 | 32301970 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 2.10e-07 | 10 | 43 | 3 | 11535246 | |
| Pubmed | 9.75e-07 | 16 | 43 | 3 | 17137217 | ||
| Pubmed | 9.75e-07 | 16 | 43 | 3 | 20691829 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20417180 | ||
| Pubmed | Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes. | 1.49e-06 | 2 | 43 | 2 | 16419488 | |
| Pubmed | Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. | 1.49e-06 | 2 | 43 | 2 | 18375436 | |
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 1.49e-06 | 2 | 43 | 2 | 14871892 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 20099167 | ||
| Pubmed | Lipoprotein lipase and endothelial lipase in human testis and in germ cell neoplasms. | 1.49e-06 | 2 | 43 | 2 | 19780863 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17093291 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 1.49e-06 | 2 | 43 | 2 | 10762004 | |
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 1.49e-06 | 2 | 43 | 2 | 8117269 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 9566757 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17356047 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 14634011 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 1.49e-06 | 2 | 43 | 2 | 23358261 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15630456 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 8093002 | ||
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 1.49e-06 | 2 | 43 | 2 | 38069221 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 11207031 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 1.49e-06 | 2 | 43 | 2 | 20936502 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12469224 | ||
| Pubmed | Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes. | 1.49e-06 | 2 | 43 | 2 | 16989840 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 31145702 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 11790777 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 10617600 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 16133548 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 10543947 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 8033246 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 1.49e-06 | 2 | 43 | 2 | 7581483 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 29705271 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15752422 | ||
| Pubmed | 1.68e-06 | 19 | 43 | 3 | 19148283 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 1.96e-06 | 72 | 43 | 4 | 8075499 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 7695643 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 25616663 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 4.48e-06 | 3 | 43 | 2 | 26067475 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 7961757 | ||
| Pubmed | Characterization of the lipolytic activity of endothelial lipase. | 4.48e-06 | 3 | 43 | 2 | 12032167 | |
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 4.48e-06 | 3 | 43 | 2 | 24039991 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 19772655 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26455829 | ||
| Pubmed | Higher order lipase gene association with plasma triglycerides. | 4.48e-06 | 3 | 43 | 2 | 15961789 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 18259693 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 12044583 | ||
| Pubmed | Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity. | 4.48e-06 | 3 | 43 | 2 | 24458708 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23991054 | ||
| Pubmed | 6.29e-06 | 29 | 43 | 3 | 20167577 | ||
| Pubmed | 6.98e-06 | 30 | 43 | 3 | 19936222 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15256516 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 8661000 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17644777 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20031538 | ||
| Pubmed | 9.36e-06 | 33 | 43 | 3 | 18193044 | ||
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 1.03e-05 | 34 | 43 | 3 | 19060911 | |
| Pubmed | Newly identified loci that influence lipid concentrations and risk of coronary artery disease. | 1.12e-05 | 35 | 43 | 3 | 18193043 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 8013374 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 26169578 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 35738281 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 19642912 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 18187430 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 15699916 | ||
| Interaction | SULT1C2 interactions | 4.54e-08 | 19 | 39 | 4 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 1.24e-07 | 24 | 39 | 4 | int:SULT1A3 | |
| Interaction | SULT1A4 interactions | 2.40e-06 | 14 | 39 | 3 | int:SULT1A4 | |
| Interaction | SULT1A2 interactions | 6.35e-06 | 19 | 39 | 3 | int:SULT1A2 | |
| Interaction | SULT1A1 interactions | 8.41e-06 | 67 | 39 | 4 | int:SULT1A1 | |
| Interaction | SULT4A1 interactions | 1.32e-05 | 24 | 39 | 3 | int:SULT4A1 | |
| Interaction | SULT1B1 interactions | 1.01e-04 | 8 | 39 | 2 | int:SULT1B1 | |
| Interaction | CANX interactions | VLDLR APOB MOXD1 NPTX1 CCDC198 LIPG UGGT1 SEC62 RNF113A SLC4A1 | 1.06e-04 | 1261 | 39 | 10 | int:CANX |
| Cytoband | 9q31.1 | 7.96e-06 | 41 | 43 | 3 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 1.35e-04 | 278 | 43 | 4 | chr16p11 | |
| Cytoband | 16p12.1 | 2.54e-04 | 25 | 43 | 2 | 16p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 2.94e-04 | 137 | 43 | 3 | chr9q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p24 | 4.40e-03 | 105 | 43 | 2 | chr9p24 | |
| GeneFamily | Sulfotransferases, cytosolic | 5.28e-09 | 14 | 29 | 4 | 762 | |
| GeneFamily | Olfactory receptors, family 13 | 6.43e-06 | 23 | 29 | 3 | 162 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 5.63e-04 | 22 | 29 | 2 | 464 | |
| GeneFamily | Olfactory receptors, family 8 | 2.79e-03 | 49 | 29 | 2 | 155 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 3.91e-08 | 24 | 38 | 4 | MM1317 | |
| Coexpression | LE_EGR2_TARGETS_DN | 7.26e-07 | 117 | 38 | 5 | MM1139 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.70e-06 | 805 | 38 | 9 | MM1067 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 2.86e-06 | 68 | 38 | 4 | MM770 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 4.24e-06 | 75 | 38 | 4 | MM1084 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 5.84e-06 | 490 | 38 | 7 | MM1001 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 6.67e-06 | 84 | 38 | 4 | MM873 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 1.81e-05 | 108 | 38 | 4 | MM1334 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 2.04e-05 | 5 | 38 | 2 | M41007 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 4.34e-05 | 135 | 38 | 4 | MM753 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 5.86e-05 | 289 | 38 | 5 | MM1238 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 6.04e-05 | 147 | 38 | 4 | MM3753 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 6.96e-05 | 491 | 38 | 6 | MM455 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 7.07e-05 | 723 | 38 | 7 | MM3672 | |
| Coexpression | JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN | 7.22e-05 | 302 | 38 | 5 | M38975 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 7.61e-05 | 156 | 38 | 4 | MM550 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 7.80e-05 | 157 | 38 | 4 | MM1099 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_ASTROCYTES | 1.06e-04 | 170 | 38 | 4 | M40162 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN | 1.98e-04 | 200 | 38 | 4 | M5818 | |
| Coexpression | GSE40273_EOS_KO_VS_WT_TREG_UP | 1.98e-04 | 200 | 38 | 4 | M9127 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP | 2.11e-04 | 380 | 38 | 5 | M38974 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_ASTROCYTES | 2.22e-04 | 206 | 38 | 4 | M40171 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.52e-05 | 84 | 38 | 4 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 6.79e-05 | 123 | 38 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#1_top-relative-expression-ranked_100 | 8.67e-05 | 8 | 38 | 2 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_100_k1 | |
| CoexpressionAtlas | EB bone marrow_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.30e-04 | 446 | 38 | 6 | PCBC_ratio_EB bone marrow_vs_EB blastocyst_cfr-2X-p05 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-07 | 182 | 43 | 5 | f6717e97e87513384149800c9fd8dea821ab9393 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-07 | 182 | 43 | 5 | c33b0d532822186a1e8e645500347972468718c0 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-07 | 187 | 43 | 5 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 1.08e-06 | 190 | 43 | 5 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 1.08e-06 | 190 | 43 | 5 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-34|World / Primary Cells by Cluster | 1.16e-06 | 193 | 43 | 5 | d55f792eb3db10452347681131e07e041348fd89 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.19e-06 | 194 | 43 | 5 | 7c6c0376603e5fcb64814fd6204d153629c2fbf5 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 1.19e-06 | 194 | 43 | 5 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-06 | 198 | 43 | 5 | 72dc49aa107d0cc6206eb67b577c73e190855125 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-06 | 198 | 43 | 5 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-06 | 199 | 43 | 5 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-06 | 200 | 43 | 5 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-06 | 200 | 43 | 5 | ed4a41cb6782541d8fc928aaa12cf03bc1c630a2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-06 | 200 | 43 | 5 | 38b51f337e183011e3ff32997ec26d8a424c6b78 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.39e-06 | 200 | 43 | 5 | 792fef1f3e47ce5c131fedfad55075fc254aeead | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 169 | 43 | 4 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 171 | 43 | 4 | 6a2f88c2a62cb2f69797804e24eb1137a3e148de | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 171 | 43 | 4 | 9be3554626408bb897d1f1c43b3ab4a92651f2e2 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-05 | 179 | 43 | 4 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 187 | 43 | 4 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.21e-05 | 188 | 43 | 4 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 3.63e-05 | 194 | 43 | 4 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 3.63e-05 | 194 | 43 | 4 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 196 | 43 | 4 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 196 | 43 | 4 | d74e899cc120146dded3a20716e22c7aca4f074a | |
| ToppCell | droplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-05 | 196 | 43 | 4 | b880c9665d42c76ea1971d4e49d7ecf72fcfafb6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.85e-05 | 197 | 43 | 4 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.85e-05 | 197 | 43 | 4 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 3.85e-05 | 197 | 43 | 4 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 3.93e-05 | 198 | 43 | 4 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-05 | 199 | 43 | 4 | 0fee11bd72b27202f8d9fa4daba831ea9c8a61b2 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.08e-05 | 200 | 43 | 4 | 4477591efada4007bab1f689017e3ac285267d29 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 4.08e-05 | 200 | 43 | 4 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| Drug | deoxoestrone | 2.91e-11 | 14 | 41 | 5 | CID000005888 | |
| Drug | 4-octylphenol | 2.37e-10 | 47 | 41 | 6 | CID000015730 | |
| Drug | luciferyl sulfate | 3.15e-10 | 7 | 41 | 4 | CID011953812 | |
| Drug | dopamine-4-O-sulfate | 3.15e-10 | 7 | 41 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 3.15e-10 | 7 | 41 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 3.15e-10 | 7 | 41 | 4 | CID003035977 | |
| Drug | 2-iodophenol | 6.30e-10 | 8 | 41 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 6.30e-10 | 8 | 41 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 6.30e-10 | 8 | 41 | 4 | CID003037707 | |
| Drug | 1m2q | 9.41e-10 | 26 | 41 | 5 | CID005326637 | |
| Drug | 4-nonylphenol | 1.62e-09 | 64 | 41 | 6 | CID000001752 | |
| Drug | EM-139 | 6.39e-09 | 13 | 41 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 8.94e-09 | 14 | 41 | 4 | CID000020908 | |
| Drug | d-equilenin | 1.05e-08 | 41 | 41 | 5 | CID000010597 | |
| Drug | arylsulfate | 1.22e-08 | 15 | 41 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 1.22e-08 | 15 | 41 | 4 | CID000002895 | |
| Drug | Woodward's reagent K | 1.35e-08 | 43 | 41 | 5 | CID000077804 | |
| Drug | A-44 | 1.62e-08 | 16 | 41 | 4 | CID000120353 | |
| Drug | benzilic acid | 2.12e-08 | 17 | 41 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 3.44e-08 | 19 | 41 | 4 | CID000115063 | |
| Drug | pedunculagin | 3.44e-08 | 19 | 41 | 4 | CID000442688 | |
| Drug | PLP-Glu | 4.29e-08 | 20 | 41 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 5.30e-08 | 21 | 41 | 4 | CID000005895 | |
| Drug | gallic acid | 5.97e-08 | 116 | 41 | 6 | CID000000370 | |
| Drug | MeA alpha C | 6.46e-08 | 22 | 41 | 4 | CID000062244 | |
| Drug | AABSSN | 6.46e-08 | 22 | 41 | 4 | CID005464134 | |
| Drug | taselin | 7.82e-08 | 23 | 41 | 4 | CID000023846 | |
| Drug | AalphaC | 9.37e-08 | 24 | 41 | 4 | CID000062805 | |
| Drug | minoxidil sulphate | 1.11e-07 | 25 | 41 | 4 | CID000004202 | |
| Drug | 2-pentanone | 1.11e-07 | 25 | 41 | 4 | CID000007895 | |
| Drug | AzMC | 1.11e-07 | 25 | 41 | 4 | CID000064986 | |
| Drug | alpha-methyldopamine | 1.31e-07 | 26 | 41 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 1.31e-07 | 26 | 41 | 4 | CID000115245 | |
| Drug | Phosphoadenosine Phosphosulfate | 1.89e-07 | 7 | 41 | 3 | ctd:D010724 | |
| Drug | Glu-P-2 | 2.08e-07 | 29 | 41 | 4 | CID000049970 | |
| Drug | 3,3'-T2 | 2.40e-07 | 30 | 41 | 4 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 2.75e-07 | 31 | 41 | 4 | CID000122642 | |
| Drug | barium hydroxide | 2.75e-07 | 31 | 41 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 2.75e-07 | 31 | 41 | 4 | CID000083939 | |
| Drug | 4-hydroxyestradiol | 3.01e-07 | 79 | 41 | 5 | CID000001743 | |
| Drug | N-hydroxy-4-aminobiphenyl | 3.02e-07 | 8 | 41 | 3 | ctd:C014593 | |
| Drug | DCNP | 3.56e-07 | 33 | 41 | 4 | CID000012066 | |
| Drug | probucol | 4.33e-07 | 162 | 41 | 6 | CID000004912 | |
| Drug | DNOC | 4.55e-07 | 35 | 41 | 4 | CID000010800 | |
| Drug | mefenamic acid | 5.72e-07 | 37 | 41 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 6.39e-07 | 38 | 41 | 4 | CID000007518 | |
| Drug | L-alpha-methyldopa | 9.64e-07 | 42 | 41 | 4 | CID000004138 | |
| Drug | NSC674039 | 1.17e-06 | 44 | 41 | 4 | CID000001249 | |
| Drug | 1IIg | 1.28e-06 | 45 | 41 | 4 | CID000001682 | |
| Drug | NDPS | 1.28e-06 | 45 | 41 | 4 | CID000090363 | |
| Drug | sulfamethazine | 1.66e-06 | 48 | 41 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 1.66e-06 | 48 | 41 | 4 | CID000005896 | |
| Drug | salicylamide | 1.66e-06 | 48 | 41 | 4 | CID000005147 | |
| Drug | pentachlorophenol | 2.41e-06 | 120 | 41 | 5 | CID000000992 | |
| Drug | 9-hydroxybenzo(a)pyrene | 2.49e-06 | 53 | 41 | 4 | CID000028598 | |
| Drug | phenylglyoxal | 2.51e-06 | 121 | 41 | 5 | CID000014090 | |
| Drug | minoxidil | 2.68e-06 | 54 | 41 | 4 | CID000004201 | |
| Drug | androstenediol | 2.68e-06 | 54 | 41 | 4 | CID000010634 | |
| Drug | MeIQx | 2.89e-06 | 55 | 41 | 4 | CID000062275 | |
| Drug | 5-hydroxymethylfurfural | 3.16e-06 | 2 | 41 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 3.16e-06 | 2 | 41 | 2 | ctd:C012365 | |
| Drug | Hydroxytryptophol | 3.16e-06 | 2 | 41 | 2 | ctd:D006917 | |
| Drug | tyramine | 3.57e-06 | 130 | 41 | 5 | CID000005610 | |
| Drug | NSC36919 | 3.58e-06 | 58 | 41 | 4 | CID000235496 | |
| Drug | 4-hydroxyestrone | 3.83e-06 | 59 | 41 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 3.83e-06 | 59 | 41 | 4 | CID000083944 | |
| Drug | 3-OHBaP | 4.99e-06 | 63 | 41 | 4 | CID000025890 | |
| Drug | corilagin | 5.66e-06 | 65 | 41 | 4 | CID000073568 | |
| Drug | epicatechin-3-gallate | 5.66e-06 | 65 | 41 | 4 | CID000065056 | |
| Drug | Pyrethroids | 8.06e-06 | 71 | 41 | 4 | CID000005053 | |
| Drug | adenylylsulfate | 8.52e-06 | 72 | 41 | 4 | CID000000228 | |
| Drug | 5-hydroxyindole | 9.48e-06 | 3 | 41 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 9.48e-06 | 3 | 41 | 2 | ctd:D008914 | |
| Drug | 5-hydroxy-3-methylindole | 9.48e-06 | 3 | 41 | 2 | CID000192734 | |
| Drug | 8-azaadenine | 9.48e-06 | 3 | 41 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 9.48e-06 | 3 | 41 | 2 | ctd:C030629 | |
| Drug | 7-hydroxycoumarin | 1.00e-05 | 75 | 41 | 4 | CID005281426 | |
| Drug | benzyloxyresorufin | 1.17e-05 | 78 | 41 | 4 | CID000114982 | |
| Drug | reverse T3 | 1.43e-05 | 82 | 41 | 4 | CID000022069 | |
| Drug | Minilyn | 1.89e-05 | 4 | 41 | 2 | CID000066463 | |
| Drug | Chebi:32701 | 1.89e-05 | 4 | 41 | 2 | CID005460855 | |
| Drug | 4-aminobiphenyl | 2.25e-05 | 92 | 41 | 4 | CID000007102 | |
| Drug | p-nitroanisole | 2.25e-05 | 92 | 41 | 4 | CID000007485 | |
| Drug | 2-naphthol | 2.35e-05 | 93 | 41 | 4 | CID000008663 | |
| Drug | 1-naphthol | 2.89e-05 | 98 | 41 | 4 | CID000007005 | |
| Drug | adenosine 3'-5'-diphosphate | 2.89e-05 | 98 | 41 | 4 | CID000000073 | |
| Drug | 4-(3,6-dimethylheptan-3-yl)phenol | 3.12e-05 | 34 | 41 | 3 | CID010633340 | |
| Drug | 1 C2 | 3.13e-05 | 100 | 41 | 4 | CID005327152 | |
| Drug | DRF 2519 | 3.15e-05 | 5 | 41 | 2 | CID009908833 | |
| Drug | pinocembrin | 3.15e-05 | 5 | 41 | 2 | ctd:C016063 | |
| Drug | TKPP | 3.15e-05 | 5 | 41 | 2 | CID000023740 | |
| Drug | harmol | 3.15e-05 | 5 | 41 | 2 | ctd:C001326 | |
| Drug | A21250 | 3.79e-05 | 105 | 41 | 4 | CID000000990 | |
| Drug | 2-naphthylamine | 4.55e-05 | 110 | 41 | 4 | CID000007057 | |
| Drug | 2-Sulfotrehalose | 4.72e-05 | 6 | 41 | 2 | CID000124677 | |
| Drug | N-hydroxy-2-acetylaminophenanthrene | 4.72e-05 | 6 | 41 | 2 | CID000017102 | |
| Drug | He I | 6.36e-05 | 43 | 41 | 3 | CID000094789 | |
| Drug | AC1L577W | 6.61e-05 | 7 | 41 | 2 | CID000171279 | |
| Drug | N-acetyl-2-naphthylhydroxylamine | 6.61e-05 | 7 | 41 | 2 | CID000017272 | |
| Drug | o-chlorobenzylsulfonamide | 6.61e-05 | 7 | 41 | 2 | CID000146065 | |
| Disease | cholesterol to total lipids in small LDL percentage | 6.11e-06 | 27 | 39 | 3 | EFO_0022241 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 6.11e-06 | 27 | 39 | 3 | EFO_0022238 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.61e-05 | 37 | 39 | 3 | EFO_0022281 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.61e-05 | 37 | 39 | 3 | EFO_0022252 | |
| Disease | degree of unsaturation measurement | 1.89e-05 | 39 | 39 | 3 | EFO_0022261 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 2.36e-05 | 42 | 39 | 3 | EFO_0022255 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 2.54e-05 | 43 | 39 | 3 | EFO_0022254 | |
| Disease | total lipids in very small VLDL measurement | 2.91e-05 | 45 | 39 | 3 | EFO_0022156 | |
| Disease | saturated fatty acids measurement | 2.91e-05 | 45 | 39 | 3 | EFO_0022304 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 3.77e-05 | 49 | 39 | 3 | EFO_0021897 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.01e-05 | 50 | 39 | 3 | EFO_0022247 | |
| Disease | cholesterol to total lipids in small HDL percentage | 4.25e-05 | 51 | 39 | 3 | EFO_0022240 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 4.74e-05 | 8 | 39 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | triglycerides in HDL measurement | 4.78e-05 | 53 | 39 | 3 | EFO_0022317 | |
| Disease | triglycerides in medium HDL measurement | 5.05e-05 | 54 | 39 | 3 | EFO_0022321 | |
| Disease | triglycerides in very large HDL measurement | 5.34e-05 | 55 | 39 | 3 | EFO_0022324 | |
| Disease | phospholipids in medium HDL measurement | 5.34e-05 | 55 | 39 | 3 | EFO_0022295 | |
| Disease | cholesterol in IDL measurement | 6.26e-05 | 58 | 39 | 3 | EFO_0021899 | |
| Disease | total lipids in medium HDL measurement | 6.26e-05 | 58 | 39 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 6.26e-05 | 58 | 39 | 3 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 6.59e-05 | 59 | 39 | 3 | EFO_0021903 | |
| Disease | total lipids in IDL | 6.93e-05 | 60 | 39 | 3 | EFO_0022161 | |
| Disease | free cholesterol in HDL measurement | 7.29e-05 | 61 | 39 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 7.29e-05 | 61 | 39 | 3 | EFO_0022293 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 7.61e-05 | 10 | 39 | 2 | OBA_2045163 | |
| Disease | total lipids in HDL measurement | 8.02e-05 | 63 | 39 | 3 | EFO_0022307 | |
| Disease | total lipids in very large HDL measurement | 9.22e-05 | 66 | 39 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 9.22e-05 | 66 | 39 | 3 | EFO_0022298 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 9.64e-05 | 67 | 39 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | integral membrane protein 2B measurement | 1.11e-04 | 12 | 39 | 2 | EFO_0802634 | |
| Disease | focal segmental glomerulosclerosis (biomarker_via_orthology) | 1.11e-04 | 12 | 39 | 2 | DOID:1312 (biomarker_via_orthology) | |
| Disease | X-12707 measurement | 1.11e-04 | 12 | 39 | 2 | EFO_0800720 | |
| Disease | phospholipids in large HDL measurement | 1.25e-04 | 73 | 39 | 3 | EFO_0022190 | |
| Disease | total lipids in large HDL | 1.30e-04 | 74 | 39 | 3 | EFO_0022189 | |
| Disease | Hyperlipoproteinemia Type IIb | 1.32e-04 | 13 | 39 | 2 | C1704417 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.52e-04 | 78 | 39 | 3 | EFO_0022187 | |
| Disease | ascorbic acid 3-sulfate measurement | 1.53e-04 | 14 | 39 | 2 | EFO_0800173 | |
| Disease | free cholesterol in large HDL measurement | 1.57e-04 | 79 | 39 | 3 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 1.63e-04 | 80 | 39 | 3 | EFO_0021900 | |
| Disease | Hypertriglyceridemia | 1.77e-04 | 15 | 39 | 2 | C0020557 | |
| Disease | low density lipoprotein triglyceride measurement | 1.77e-04 | 15 | 39 | 2 | EFO_0009946 | |
| Disease | triacylglycerol 52:3 measurement | 1.77e-04 | 15 | 39 | 2 | EFO_0010415 | |
| Disease | Hyperlipoproteinemia Type IIa | 2.02e-04 | 16 | 39 | 2 | C0745103 | |
| Disease | Autosome Abnormalities | 2.02e-04 | 16 | 39 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 2.02e-04 | 16 | 39 | 2 | C0008625 | |
| Disease | Lipidemias | 2.29e-04 | 17 | 39 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 2.29e-04 | 17 | 39 | 2 | C0020473 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.57e-04 | 18 | 39 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Hypercholesterolemia, Familial | 2.57e-04 | 18 | 39 | 2 | C0020445 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.63e-04 | 94 | 39 | 3 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.80e-04 | 96 | 39 | 3 | EFO_0004529, EFO_0008595 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.87e-04 | 19 | 39 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 3.07e-04 | 99 | 39 | 3 | EFO_0004574, EFO_0008595 | |
| Disease | coronary artery disease (is_implicated_in) | 3.16e-04 | 100 | 39 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.45e-04 | 103 | 39 | 3 | EFO_0008595, EFO_0020944 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 3.52e-04 | 21 | 39 | 2 | EFO_0022262 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.54e-04 | 104 | 39 | 3 | EFO_0008591, EFO_0008595 | |
| Disease | lipoprotein measurement | 3.65e-04 | 105 | 39 | 3 | EFO_0004732 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 3.85e-04 | 107 | 39 | 3 | EFO_0004614, EFO_0004615 | |
| Disease | remnant cholesterol measurement | 3.96e-04 | 108 | 39 | 3 | EFO_0010815 | |
| Disease | Dyslipidemias | 4.61e-04 | 24 | 39 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 4.61e-04 | 24 | 39 | 2 | C0598784 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 4.61e-04 | 24 | 39 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 5.13e-04 | 118 | 39 | 3 | EFO_0010119 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 5.42e-04 | 26 | 39 | 2 | EFO_0004612, MONDO_0004975 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.52e-04 | 121 | 39 | 3 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 5.52e-04 | 121 | 39 | 3 | EFO_0004612, EFO_0005271 | |
| Disease | docosahexaenoic acid measurement | 6.35e-04 | 127 | 39 | 3 | EFO_0007761 | |
| Disease | esterified cholesterol measurement | 6.50e-04 | 128 | 39 | 3 | EFO_0008589 | |
| Disease | choline measurement | 6.80e-04 | 130 | 39 | 3 | EFO_0010116 | |
| Disease | polyunsaturated fatty acid measurement | 6.95e-04 | 131 | 39 | 3 | EFO_0010733 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 7.73e-04 | 31 | 39 | 2 | EFO_0022249 | |
| Disease | microcephaly (implicated_via_orthology) | 8.23e-04 | 32 | 39 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.15e-04 | 144 | 39 | 3 | EFO_0004611, EFO_0020943 | |
| Disease | free cholesterol in small HDL measurement | 9.85e-04 | 35 | 39 | 2 | EFO_0022270 | |
| Disease | cholesterol in small HDL measurement | 1.04e-03 | 36 | 39 | 2 | EFO_0022226 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.04e-03 | 36 | 39 | 2 | EFO_0022257 | |
| Disease | Cardiovascular Diseases | 1.04e-03 | 36 | 39 | 2 | C0007222 | |
| Disease | triacylglycerol 52:4 measurement | 1.04e-03 | 36 | 39 | 2 | EFO_0010416 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.09e-03 | 153 | 39 | 3 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.09e-03 | 153 | 39 | 3 | EFO_0004611, EFO_0020944 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 1.22e-03 | 39 | 39 | 2 | EFO_0022332 | |
| Disease | Hypercholesterolemia | 1.22e-03 | 39 | 39 | 2 | C0020443 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0004746 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0005110, EFO_0007761 | |
| Disease | cholesterol in very small VLDL measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0022231 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QKKKARMSKMNEYFS | 61 | P0DKL9 | |
| MMLRKFKNSSYFPGK | 586 | P02730 | |
| TNYMYAKVKKSLPEM | 236 | Q15818 | |
| YSMQKKKPRELMNFK | 251 | Q3ZCV2 | |
| SEMMKKPSQAPKYRT | 466 | Q0VAK6 | |
| SKMYLKTRSQMPYKV | 326 | P06858 | |
| AMQRKPKSYSSSLMD | 671 | Q9H0H0 | |
| YPQTMTSEMKKKGFN | 81 | Q6ZR08 | |
| NSKMYLKTRAGMPFR | 331 | Q9Y5X9 | |
| ANKKMKNLMVYSLPT | 326 | P50748 | |
| LFMYMKPKSKETLNS | 256 | Q8NGS9 | |
| VFTPKMLMNFVSKKN | 76 | Q8NGG8 | |
| INNYQKYMKPKDTSM | 156 | O15541 | |
| KYMKPKDTSMGNASS | 161 | O15541 | |
| GKYKNFATSNKMDMT | 1576 | P04114 | |
| MKPKMKYSTNKISTA | 1 | O95760 | |
| APMMAKTIKAFKNRF | 781 | Q14241 | |
| MNSKESKFTFKMNPG | 321 | O75936 | |
| FPPNHMSNTKASKMK | 3876 | Q12955 | |
| KKMQTPMYTSENRQY | 136 | Q9NVL8 | |
| KMYKHSNNKAMTTGA | 101 | P20618 | |
| VFTPKMLMNFVSKKN | 76 | Q96RD0 | |
| NPFIYSMRNKDMKAA | 301 | Q8NH06 | |
| LFMYMKPKSKETLNS | 256 | Q8NGT0 | |
| SALFMYMKPKSKNTN | 286 | Q8NGV5 | |
| PDNKNSKKMMHYFSQ | 1426 | O60522 | |
| KLIFQMPQNKSTKFM | 901 | Q13576 | |
| TTSMRTPNFNMYVKK | 851 | Q9NTG1 | |
| PVQMMFKQSTFKKTY | 196 | P35237 | |
| SQNMMESLSPKKYSS | 31 | Q86SQ0 | |
| HTSFKEMKKNPMTNY | 226 | P0DMN0 | |
| HTSFKEMKKNPMTNY | 226 | P0DMM9 | |
| MRASMDPKRFYKKND | 666 | Q5QJE6 | |
| SPNNMSFATKKYMKR | 1111 | Q15468 | |
| MVKMTKSKTFQAYLP | 1 | O60688 | |
| MSTSLNPMRKKSYKS | 121 | Q5T5D7 | |
| SPKQYKNLSFMDAMN | 511 | Q6UVY6 | |
| KYLRFNCPTKSTNMM | 26 | Q99442 | |
| HTSFKEMKKNPMTNY | 226 | P50225 | |
| HTSFKEMKKNPMTNY | 226 | P50226 | |
| MKAFVENYPQFKKMS | 311 | Q9NRW7 | |
| TLAAYSKMMSPLKNS | 536 | Q8TCN5 | |
| ANSMNYLTKKGMSSK | 736 | Q9NYU2 | |
| NMKSMNFDNPVYLKT | 826 | P98155 | |
| YEKASKRMTFQMPKF | 231 | Q9NP98 |